Free Trial
NYSEARCA:TERM

EquityCompass Tactical Risk Manager ETF (TERM) Price, Holdings, & News

$22.15 +0.13 (+0.59%)
As of 10/15/2021

About EquityCompass Tactical Risk Manager ETF (NYSEARCA:TERM)

Key Stats

Today's Range
$22.15
$22.15
50-Day Range
$22.15
$22.15
52-Week Range
$15.07
$22.43
Volume
700 shs
Average Volume
1,478 shs
Market Capitalization
$12.18 million
Assets Under Management
$12.12 million
Dividend Yield
1.31%
Net Expense Ratio
0.67%
Aggregate Rating
N/A

ETF Overview

EquityCompass Tactical Risk Manager ETF Expenses

TypeTERMLong/Short ETFsMulti Asset ETFsNYSEARCA ETFsAll ETFs
Management Fee0.65%0.84%0.70%0.51%0.53%
Other Expenses0.02%2.77%0.71%0.59%0.56%
Total Expense0.67%2.54%1.19%0.74%0.73%
Fee Waiver0.00%-3.09%-0.60%-0.71%-0.63%
Net Expense0.67%1.42%0.96%0.58%0.60%
Receive TERM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EquityCompass Tactical Risk Manager ETF and its competitors with MarketBeat's FREE daily newsletter.

TERM ETF News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
6 ETFs Focused on Gender Equality
Are Covered Call ETFs a Good Investment?
Conquer Risk Tactical Opportunities
See More Headlines

TERM ETF - Frequently Asked Questions

EquityCompass Tactical Risk Manager ETF's stock was trading at $22.15 at the start of the year. Since then, TERM stock has increased by 0.0% and is now trading at $22.15.

Shares of TERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that EquityCompass Tactical Risk Manager ETF investors own include Aldeyra Therapeutics (ALDX), Biodexa Pharmaceuticals (BDRX), Candel Therapeutics (CADL), Cleanspark (CLSK), CXApp (CXAI), DiaMedica Therapeutics (DMAC) and Dyne Therapeutics (DYN).

Fund Details

Issuer
First Trust
Fund Name
EquityCompass Tactical Risk Manager ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:TERM
Inception Date
4/10/2017
Fund Manager
Timothy M. McCann, Bernard J. Kavanagh
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Multi Asset
Benchmark
N/A
Category
Absolute Returns
Focus
Long/Short
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$12.12 million
Average Daily Volume
$654.90
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

TERM Sector Exposure

TERM Industry Exposure


This page (NYSEARCA:TERM) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners